
    
      Single oral administration of 40 mg study drug lurasidone or placebo after the over 350 kcal
      breakfast on Day 1. Administration was suspended on Days 2 and 3. Continuous oral
      administration of 40 mg study drug lurasidone or placebo, once daily between Day 4 and Day 8.
    
  